Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

The country's new government has promised to prioritise primary care and public health spending after years of neglect. Samaan Lateef reports.

Imagine if a nasal spray could make you immune not only to the viruses that cause COVID-19 and influenza, but to all respiratory diseases. In a paper 1 published in Science today, researchers describe ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

Feb 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

The U.S. Food and Drug Administration will review a messenger RNA (mRNA) flu vaccine for approval, according to its maker, Moderna. The decision is a dramatic U-turn for the agency, which, only about ...

Grattan Institute has been supported in its work by government, corporates, and philanthropic gifts. A full list of supporting organisations is published at www.grattan.edu.au. Child vaccination has ...

The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval. The refusal was revealed last week in a sharply worded press release from ...

Bangladesh Nationalist Party (BNP) chief Tarique Rahman pays a courtesy visit to Jamaat-e-Islami leader Dr. Shafiqur Rahman at the latter’s residence, following the BNP’s sweeping victory in the ...

This is read by an automated voice. Please report any issues or inconsistencies here. DHAKA, Bangladesh — Bangladesh’ s new prime minister was sworn in on Tuesday after his party’s landslide win in ...

The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...